| Literature DB >> 35558110 |
Anne Bhambri1, Malay Srivastava2, Vivek G Mahale2, Sushma Mahale2, Santosh Kumar Karn1.
Abstract
Background: Mushrooms exist as an integral and vital component of the ecosystem and are very precious fungi. Mushrooms have been traditionally used in herbal medicines for many centuries. Scope and Approach: There are a variety of medicinal mushrooms mentioned in the current work such as Agaricus, Amanita, Calocybe, Cantharellus, Cordyceps, Coprinus, Cortinarius, Ganoderma, Grifola, Huitlacoche, Hydnum, Lentinus, Morchella, Pleurotus, Rigidoporus, Tremella, Trametes sp., etc., which play a vital role in various diseases because of several metabolic components and nutritional values. Medicinal mushrooms can be identified morphologically on the basis of their size, color (white, black, yellow, brown, cream, pink and purple-brown, etc.), chemical reactions, consistency of the stalk and cap, mode of attachment of the gills to the stalk, and spore color and mass, and further identified at a molecular level by Internal Transcribed Spacer (ITS) regions of gene sequencing. There are also other methods that have recently begun to be used for the identification of mushrooms such as high-pressure liquid chromatography (HPLC), nuclear magnetic resonance spectroscopy (NMR), microscopy, thin-layer chromatography (TLC), DNA sequencing, gas chromatography-mass spectrometry (GC-MS), chemical finger printing, ultra-performance liquid chromatography (UPLC), fourier transform infrared spectroscopy (FTIR), liquid chromatography quadrupole time-of-flight mass spectrometry (LCMS-TOF) and high-performance thin-layer chromatography (HPTLC). Lately, the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) technique is also used for the identification of fungi. Key Finding andEntities:
Keywords: ITS sequence; medicine; metabolites; mushroom; polyketides etc; terpenoids; unknown metabolites; β-glucan
Year: 2022 PMID: 35558110 PMCID: PMC9090473 DOI: 10.3389/fmicb.2022.837266
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
FIGURE 1Structures of active metabolites of mushroom: (A) Lectins (Butt and Khan, 2019) (B) Glycoprotein (National Center for Biotechnology Information [NCBI], 2022b).
FIGURE 5Structures of active metabolites of mushroom: (A) Terpenoids (Yadava et al., 2014) (B) Lectins (Butt and Khan, 2019).
FIGURE 6Representing the wide applications of mushroom.
Showing mushroom metabolites, mechanism and their applications.
| S.No. | Name of Medicinal Mushroom | Metabolite components | Treatment/Applications | Mechanism | References |
|
|
| Carbohydrates, Lipids, Proteins, Flavanols, Bioflavonoids, Iso-flavonoids, Flavones, Flavanone, Ergosterol, β-sitosterol, Stigmast-5-en-3-ol, Hydroxy methylquinoline, Sesquiterpene, Coriolin and De-oxycoriolic acid | Antibacterial, Anticancer, Insecticidal, Antioxidant, Anti-proliferative, Anticoagulant, Antifungal, Antidiabetic, Hepatoprotective, Antiparasitic, Antiviral, Anti-inflammatory, Upper respiratory, Digestive, Urinary Tract Infections and Chronic Hepatitis | Immunostimulant, Activation of macrophage and Natural killer cell cytotoxicity. | |
|
|
| Fatty acids, Phenolics, Amino acids, Sugar and Polyols, Organic acids, Lectins, Unsaturated fatty acids (linoleic and linolenic acids), Sterols, Phenolic, Indole compounds and Nutraceuticals | Liver Disease, Cancer, Digestive Problems, High cholesterol, Type 2 Diabetes, Arteriosclerosis, Bloodstream Disorders, Heart Disease, Osteoporosis and Stomach Ulcers | Inhibit cell proliferation of some cancer cell line, Antioxidant activities, Anti-inflammatory | |
|
|
| Triterpenoids, Polysaccharides, Proteins and Peptides, Terpenoids, Phenols, Glycoproteins, Triterpenes, Amino acids (Lysine and Leucine), Ganodermic acids, Nucleotides and their derivatives, Peptidoglycans and Steroids | Diabetes, Infections, Cancer, Immune System Disorders, Hepatoprotection, Bacterostasis, Bronchitis, Gastric Ulcer, Hepatopathy, Asthma, Insomnia, Chronic Hepatitis, Nephritis, Arthritis, Hypertension, Weakness, Fatigue, Cough, Anti-atherosclerosis, Anti-oxidant, Anti-HIV, Nephroprotective, Anti-tumor, Anti-hepatotoxic, Cardiovascular, respiratory Properties. It also decreases the level of blood pressure, Inhibition of platelet aggregation as well asblood cholesterol, Anti-inflammatory, Analgesic, Chemopreventive, Chemo &Radio protective, Sleep promoting, Antibacterial, Antiviral, Hypolipidemic, Anti-fibrotic, Anti-&rogenic, Anti-angiogenic, Anti-herpetic, Radical-scavenging, Anti-aging, Hypoglycemic, Estrogenic activities. | Immunomodulator (interleukin – 12 production), Nitric oxide synthase activation | |
|
|
| Polyphenolic compounds such as Phenolic acids, Flavonoids, Hydroxybenzoic acids, Lignans, Tannins, Stilbenes, Oxidized polyphenols, Ferulic acid, Sarcodonin A, Savronine B and Quercetin | Antioxidant, Antimicrobial, Genotoxic, Protective against chemotherapeutics, Cytotoxic activity against a variety of tumor cells type, mainly colon adenocarcima cells | Synthesis of nerve growth factor |
|
|
|
| Carbohydrates, Dietary fibres, Proteins and Phenolic compounds. | Regulate the blood glucose level, Hypoglycemic and has Antitumor, Antioxidative, Hypolipidemic, Antibacterial as well as Immunomodulation effects | Regulate antioxidative homeostasis |
|
|
|
| Sugars, Organic acids, Flavonoids, Triglycerides, Free fatty acids and Sterols | Anti-inflammatory as well as Antitumor activity against both ascites as well as solid tumours of ethanolic extracts, High antioxidant activity | Immunomodulator, Increase the cytotoxic effect |
|
|
|
| Phenolic compounds, Terpenes, Steroids, Lectins, Polysaccharides, Proteins, Phenolic compounds, Flavonoids, and Tannins | Excellent Antihyperglycemic, Antioxidant, Wound healing, Antimicrobial, Iron-chelation, Cytotoxicity, Anti-hypoxic, Anti-inflammatory activities | Causing Cytotoxicity against angiotensins converting enzyme | |
|
|
| Ibotenic acid, Muscazone and Muscimol | Antitumor, Pesticidal, Cytotoxic, Antioxidant, Anticancer, Antibacterial, Acetylcholinesterase, Esterolytic, Antiviral, Anti-, larvicidal, Antifungal, Anti-inflammatory properties | Induces Cascade dependent apoptosis | |
|
|
| Amino acids, Orellanine | Antioxidant, Antihyperglycemic, Wound healing, Antimicrobial, Iron-chelation, Cytotoxicity, Anti-hypoxic, Anti-acid inflammatory | Inhibit protein synthesis |
|
|
|
| Fatty acids, Proteins, Enzymes, Polysaccharides, Phenols, Flavonoid, Dietary fiber and Trace elements. | Fight cancer, Combat obesity, Anti-aging, Lower cholesterol, Protect nerves and Anti-inflammatory. | Enzyme inhibition |
|
|
|
| Anthraquinones, Alkaloids, Tannins, Saponins, Phlobatannins, Steroids, Flavonoids, Terpenoids and Cardiac glycosides. | Mitogenic activity, Anti-hepatitis B surface antigen effect, Plasma clotting activity, Activation of alternative pathway complement, Tumour suppressive effects | Exact mechanism is unknown, Antioxidant activities, Anti-inflammatory |
|
|
|
| Polysaccharide (glucans), Sesquiterpenes, Glycoproteins etc. | Antitumor, Anti-inflammation, Immunomodulation, Antivirus, Antidiabetic, Immune-enhancing, Anti-hypertensive, Antioxidation, Non-alcoholic fatty liver disease, Hyperlipidemia and Hyperglycemia. | Immunomodulator |
|
|
|
| Phenolic compounds, Polysaccharides, Terpenoids, Sterols and Lipids | Fungal infection, Bronchial inflammation, Hyperlipidemia, Hepatitis, Cancer, Depressed immune function, Heart disease, Infectious disease, Flu and Cold, Environmental allergies, Urinary inconsistencies, Hypertension, Diabetes | Inhibitory effect on interleukin- 1β, tumour necrosis factor α |
|
|
|
| Terpenoids, Steroidal glycosidase, Tannin | Anti-cholestrolic, Anticancer, Antiviral, Antidiabetic, Antioxidant, Eye health, Antibacterial and Antiarthritic. | Hypocholesterolemic, antherogenesis inhibition |
|
|
|
| Ascorbic acid, Lipids, Riboflavin, Amino acids, Pyridoxine, Vitamins, Biotin, Low fat, Nicotinic acid, Proteins, Minerals (arsenic, zinc, potassium, manganese, calcium, phosphorus, magnesium, iron and sodium), Fibers | Reducing the triglycerides and total plasma cholesterol level and consequently decreases the chance of cardiovascular, artery and atherosclerosis related disorders, like neurodegenerative diseases, Anti-carcinogenesis, Anti-ageing, Anti-obesity, Cardiovascular disease, Anti-infectious, prevent from physical injury, Anti-tumour also helps to reduce the risk of breast cancer | Immunomodulator, immunegenerator |
|
|
|
| Contain Anthocyanins and Phenolic compounds which are Phytochemicals, Phytosterol, Polyphenols, Flavonoids, Proteins, Amino acids, Glutamic acid, Lysine, Serine, Aspartic acid, Glycine, Total carbohydrates, Arabinose, Mannose, Galactose, Xylose, Glucitol, Mannitol, Glycerol, Heteroglycans, Dietary fiber and Homoglycans | Antitumoral, Antimutagenic, Immunomodulating, Antiatherogenic, Hyperlipidemic, Hypoglycemic, Anti-inflammatory as well as Various other health promoting activities | Exact mechanism is unknown, Antioxidant activities. |
|
|
|
| Alkaloids, Amino acids, Proteins, Carbohydrates, Flavonoids, Phenols, Gums, Mucilages, Saponins, Cordycepic acid and Cordycepin substances | Improved reproductive activity, Blood sugar metabolism, Effects of enhanced utilization of oxygen and Production of ATP. This mushroom protects the organs from kidney, liver as well as heart diseases. | Immunomodulating effects, Enhancement of neuromuscular activity, Endurance enhancing activity. |
|
Showing patented products of medicinal mushroom.
| S.No. | Claimed Product/Extract Name | Activity Claimed | Patent Application No. | Inventors |
|
| Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom | Control hyperglycaemia | US 6383799 |
|
|
| Anti-aging/menopause symptoms relief using | Anti-ageing | US 6908614 |
|
|
| Antimutagenic effects of | Antimutagenic | US 7087233 |
|
|
| Glycoprotein with antidiabetic, antihypertensive, anti-obesity and antihyperlipidemic effects from | Antidiabetic | US 7214778 |
|
|
| Mushroom extracts having anticancer activity | Anticancerous | US 7258862 |
|
|
| Phytonutrient compositions prepared from | Treatment of neurodegenerative diseases and radiation damage | WO2007US63984 20070314 |
|
|
| Food supplement prepared from | Reducing blood sugar and regulating blood lipid levels | CN 101292726 A 20081029 |
|
|
| Mushroom extract from | Anti-dementia substance inhibits the neuronal toxicity of amyloid beta-peptide (Aβ) and induce the synthesis of nerve growth factor (NGF) | US2009274720 (A1) |
|
|
| Basidiomycetes, Basidiomycetes extract composition, health foods and immunopotentiators | Immune Function | US 7517682 |
|
|
| Ganoderic acid T-amide derivative TLTO-A | Antitumor agent for inhibiting cancer cells and induce the apoptosis of tumor cells | CN102219822 |
|
|
| Method of eritadenine production in liquid phase fermentation of | Blood cholesterol reducing therapeutic agent | United States Patent 8053217 |
|
|
| Mushroom extracts from | Antidiabetic | JP 2012077004A |
|
|
| Terpenoid spiroketal compound from | Therapeutic potential on disease having Liver X Receptor (LXR) agonists activity | EP 2 468 253(A1) |
|
|
| Antiviral and antibacterial activity from medicinal mushrooms | Antiviral, Antibacterial | US 8765138 |
|
|
| Anti-cancer combination treatment and kit-of-parts | Anticancerous | US 9072776 |
|
|
| Method to prepare | anti-obesity | US 9758595 |
|
|
| Antiviral products | helps in the reduction of pathogenicviruses and treating viral infections, particularly viruses which afflict animals but not limited to pigs, birds, humans, bats and bee results in the reduction of diseases that causes viruses and their infectivity or pathogenicity in both the environment as well as in animal host. | US 9,931,316B2 |
|
FIGURE 7Representing identification and phytochemical analysis of medicinal mushroom.
FIGURE 8(A) Representation of Medicinal Mushrooms (a) Coriolus versicolor (Paul et al., 2008) (b) Agaricus sp. (Glamočlija et al., 2015) (c) Ganoderma sp. (Hong and Jung, 2004) (d) Hydnum sp. (Paul et al., 2008) (e) Coprinus sp. (Coprinus Pers, 2015) (f) Morchella sp. (Raman et al., 2018). (B) Representation of Medicinal Mushrooms (g) Cantharellus sp. (Pilz et al., 2003) (h) Amanita sp. (Tulloss, 2015) (i) Cortinarium sp. (Cortinarius (Pers.) Gray, 2020) (j) Tremella sp. (Rea, 1922) (k) Rigidoporus sp. (Rigidoporus, 1905) (l) Grifola sp. (Cetto, 2008). (C) Representation of Medicinal Mushrooms (m) Lentinus sp. (Wells, 2008) (n) Pleurotus sp. (Chang and Miles, 2004) (o) Calocybe sp. (Kirk et al., 2008) (p) Huitlacoche sp. (Spraker, 2013) (q) Cordyceps sp. (Pat O’Reilly, 2016).